A graduate of the London School of Economics and Political Science, Jacinto Solivellas de Oleza now works as a partner and senior board advisor at Olesis Management. Focusing primarily on high net-worth individuals, Jacinto Solivellas de Oleza provides financial guidance and manages more than $100 million in investible assets. He is also a supporter of the International Cancer Foundation.
Thanks to the support of donations worldwide, the International Cancer Foundation and other entities are better able to develop advanced treatments for one of the planet’s most deadly diseases. And while technologically advanced treatment methods are a welcome sight, a viable treatment could be as close as the medicine cabinet.
In 2010, Michelle Holmes and Wendy Chen, physicians and faculty members at Harvard Medical School, published an observational study in the Journal of Clinical Oncology linking aspirin to the reduction of breast cancer. According to the study, women with the disease that took aspirin at least once per week decreased their chance of dying from breast cancer by 50 percent. Randomized clinical trials are yet to be conducted, which many believe is because the affordability of aspirin could cause large pharmaceutical companies to lose billions of dollars.